Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Branford

Showing results (341-350 of 480) with videos related to

Pageof 48
Sort By:
The EMBO Journal|June 15, 1994
Gsh-4 encodes a LIM-type homeodomain, is expressed in the developing central nervous system and is required for early postnatal survivalH Li, D P Witte, W W Branford, et al.
Applied Clinical Informatics|October 13, 2016
A Two-Year Longitudinal Assessment of Ophthalmologists' Perceptions after Implementing an Electronic Health Record SystemJoshua R Ehrlich, Monica Michelotti, Taylor S Blachley, et al.
Blood|March 8, 2003
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosisSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.
Bone Marrow Transplantation|January 1, 1989
The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemiaL B To, D N Haylock, D Thorp, et al.
Integrated Environmental Assessment and Management|December 6, 2023
CropLife Europe Crop Development Database: An open-source, pan-European, harmonized crop development database for use in regulatory pesticide exposure modeling and risk assessmentGregory O Hughes, Andrew Eatherall, Michael Bird, et al.
Blood Cancer Journal|April 21, 2022
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuationShady Adnan Awad, Oscar Brück, Naranie Shanmuganathan, et al.
Physical Review Letters|August 8, 2009
Coexistence of universal and topological anomalous hall effects in metal CrO2 thin films in the dirty limitW R Branford, K A Yates, E Barkhoudarov, et al.
International Journal of Clinical Oncology|October 12, 2011
Harmonization of molecular monitoring of chronic myeloid leukemia therapy in JapanChikashi Yoshida, Linda Fletcher, Kazuteru Ohashi, et al.
Leukemia|March 27, 2024
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?Hagop Kantarjian, Susan Branford, Massimo Breccia, et al.
Bone Marrow Transplantation|April 1, 1992
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplantsL B To, M M Roberts, D N Haylock, et al.
Pageof 48

Showing results (341-350 of 480) with videos related to

Sort By:
Pageof 48
The EMBO Journal|June 15, 1994
Gsh-4 encodes a LIM-type homeodomain, is expressed in the developing central nervous system and is required for early postnatal survivalH Li, D P Witte, W W Branford, et al.
Applied Clinical Informatics|October 13, 2016
A Two-Year Longitudinal Assessment of Ophthalmologists' Perceptions after Implementing an Electronic Health Record SystemJoshua R Ehrlich, Monica Michelotti, Taylor S Blachley, et al.
Blood|March 8, 2003
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosisSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.
Bone Marrow Transplantation|January 1, 1989
The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemiaL B To, D N Haylock, D Thorp, et al.
Integrated Environmental Assessment and Management|December 6, 2023
CropLife Europe Crop Development Database: An open-source, pan-European, harmonized crop development database for use in regulatory pesticide exposure modeling and risk assessmentGregory O Hughes, Andrew Eatherall, Michael Bird, et al.
Blood Cancer Journal|April 21, 2022
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuationShady Adnan Awad, Oscar Brück, Naranie Shanmuganathan, et al.
Physical Review Letters|August 8, 2009
Coexistence of universal and topological anomalous hall effects in metal CrO2 thin films in the dirty limitW R Branford, K A Yates, E Barkhoudarov, et al.
International Journal of Clinical Oncology|October 12, 2011
Harmonization of molecular monitoring of chronic myeloid leukemia therapy in JapanChikashi Yoshida, Linda Fletcher, Kazuteru Ohashi, et al.
Leukemia|March 27, 2024
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?Hagop Kantarjian, Susan Branford, Massimo Breccia, et al.
Bone Marrow Transplantation|April 1, 1992
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplantsL B To, M M Roberts, D N Haylock, et al.
Pageof 48